Effects of antiarrhythmic drugs on premature action potential duration in canine ventricular muscle fibers

A. Varró, Hirokazu Saitoh, Borys Surawicz

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The range of premature action potential durations (APDs) during the first 100 ms of electrical restitution was determined in canine ventricular muscle fibers (VM) in the presence of lidocaine (4 and 8 μg/ml), mexiletine (8 μg/ml), flecainide (2 and 4 μg/ml), procainamide (50 μg/ml), quinidine (10 μg/ml), and disopyramide (10 μg/ml). The drug effects on the characteristics of action potential at the basic cycle lengths (BCLs) of 500 and 1,000 ms were similar to those reported previously. At control, the range of premature APDs was ∼40 ms at BCL of 1,000 ms and ∼30 ms at BCL of 500 ms. It was decreased 26-52% by lidocaine, mexiletine, and flecainide, not changed significantly by procainamide, and increased 17-53% by quinidine and disopyramide. The range of premature APDs at control and in the presence of drugs in ventricular muscle was smaller than in Purkinje fibers at the same or lower drug concentrations (Varro et al., J Pharmacol Exp Ther 1985; 233:304). The four factors influencing the premature APD range in the Purkinje fibers operated in the VM as follows: The difference between the duration of effective refractory period (ERP) and the APD at BCL (APDb) (i.e., the ERP-APDb interval) was increased by lidocaine, mexiletine, and flecainide; normalized restitution curve was shifted toward longer premature APD values only by flecainide; the kinetics of restitution were slowed only by procainamide; and APD at BCL of 1,000 ms was shortened by lidocaine and mexiletine, and prolonged at BCLs of 1,000 and 500 ms by the other four drugs. Unlike the Purkinje fibers, the range of premature APDs in VM was influenced chiefly by APD at BCL. The lengthening of the premature APD range by quinidine and disopyramide suggests that these drugs may be expected to increase dispersion of repolarization during the propagation of an early premature impulse, and that this increase may be greater at long than at short BCL.

Original languageEnglish
Pages (from-to)407-414
Number of pages8
JournalJournal of Cardiovascular Pharmacology
Volume10
Issue number4
Publication statusPublished - 1987

Fingerprint

Anti-Arrhythmia Agents
Action Potentials
Canidae
Muscles
Mexiletine
Flecainide
Disopyramide
Lidocaine
Purkinje Fibers
Procainamide
Quinidine
Pharmaceutical Preparations
pamidronate

Keywords

  • Dispersion of repolarization
  • Effective refractory period
  • Restitution of action potential duration
  • Sodium channel blocking drugs

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Effects of antiarrhythmic drugs on premature action potential duration in canine ventricular muscle fibers. / Varró, A.; Saitoh, Hirokazu; Surawicz, Borys.

In: Journal of Cardiovascular Pharmacology, Vol. 10, No. 4, 1987, p. 407-414.

Research output: Contribution to journalArticle

@article{4ae2cfbcabf1492c83325d0b05d26e1c,
title = "Effects of antiarrhythmic drugs on premature action potential duration in canine ventricular muscle fibers",
abstract = "The range of premature action potential durations (APDs) during the first 100 ms of electrical restitution was determined in canine ventricular muscle fibers (VM) in the presence of lidocaine (4 and 8 μg/ml), mexiletine (8 μg/ml), flecainide (2 and 4 μg/ml), procainamide (50 μg/ml), quinidine (10 μg/ml), and disopyramide (10 μg/ml). The drug effects on the characteristics of action potential at the basic cycle lengths (BCLs) of 500 and 1,000 ms were similar to those reported previously. At control, the range of premature APDs was ∼40 ms at BCL of 1,000 ms and ∼30 ms at BCL of 500 ms. It was decreased 26-52{\%} by lidocaine, mexiletine, and flecainide, not changed significantly by procainamide, and increased 17-53{\%} by quinidine and disopyramide. The range of premature APDs at control and in the presence of drugs in ventricular muscle was smaller than in Purkinje fibers at the same or lower drug concentrations (Varro et al., J Pharmacol Exp Ther 1985; 233:304). The four factors influencing the premature APD range in the Purkinje fibers operated in the VM as follows: The difference between the duration of effective refractory period (ERP) and the APD at BCL (APDb) (i.e., the ERP-APDb interval) was increased by lidocaine, mexiletine, and flecainide; normalized restitution curve was shifted toward longer premature APD values only by flecainide; the kinetics of restitution were slowed only by procainamide; and APD at BCL of 1,000 ms was shortened by lidocaine and mexiletine, and prolonged at BCLs of 1,000 and 500 ms by the other four drugs. Unlike the Purkinje fibers, the range of premature APDs in VM was influenced chiefly by APD at BCL. The lengthening of the premature APD range by quinidine and disopyramide suggests that these drugs may be expected to increase dispersion of repolarization during the propagation of an early premature impulse, and that this increase may be greater at long than at short BCL.",
keywords = "Dispersion of repolarization, Effective refractory period, Restitution of action potential duration, Sodium channel blocking drugs",
author = "A. Varr{\'o} and Hirokazu Saitoh and Borys Surawicz",
year = "1987",
language = "English",
volume = "10",
pages = "407--414",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Effects of antiarrhythmic drugs on premature action potential duration in canine ventricular muscle fibers

AU - Varró, A.

AU - Saitoh, Hirokazu

AU - Surawicz, Borys

PY - 1987

Y1 - 1987

N2 - The range of premature action potential durations (APDs) during the first 100 ms of electrical restitution was determined in canine ventricular muscle fibers (VM) in the presence of lidocaine (4 and 8 μg/ml), mexiletine (8 μg/ml), flecainide (2 and 4 μg/ml), procainamide (50 μg/ml), quinidine (10 μg/ml), and disopyramide (10 μg/ml). The drug effects on the characteristics of action potential at the basic cycle lengths (BCLs) of 500 and 1,000 ms were similar to those reported previously. At control, the range of premature APDs was ∼40 ms at BCL of 1,000 ms and ∼30 ms at BCL of 500 ms. It was decreased 26-52% by lidocaine, mexiletine, and flecainide, not changed significantly by procainamide, and increased 17-53% by quinidine and disopyramide. The range of premature APDs at control and in the presence of drugs in ventricular muscle was smaller than in Purkinje fibers at the same or lower drug concentrations (Varro et al., J Pharmacol Exp Ther 1985; 233:304). The four factors influencing the premature APD range in the Purkinje fibers operated in the VM as follows: The difference between the duration of effective refractory period (ERP) and the APD at BCL (APDb) (i.e., the ERP-APDb interval) was increased by lidocaine, mexiletine, and flecainide; normalized restitution curve was shifted toward longer premature APD values only by flecainide; the kinetics of restitution were slowed only by procainamide; and APD at BCL of 1,000 ms was shortened by lidocaine and mexiletine, and prolonged at BCLs of 1,000 and 500 ms by the other four drugs. Unlike the Purkinje fibers, the range of premature APDs in VM was influenced chiefly by APD at BCL. The lengthening of the premature APD range by quinidine and disopyramide suggests that these drugs may be expected to increase dispersion of repolarization during the propagation of an early premature impulse, and that this increase may be greater at long than at short BCL.

AB - The range of premature action potential durations (APDs) during the first 100 ms of electrical restitution was determined in canine ventricular muscle fibers (VM) in the presence of lidocaine (4 and 8 μg/ml), mexiletine (8 μg/ml), flecainide (2 and 4 μg/ml), procainamide (50 μg/ml), quinidine (10 μg/ml), and disopyramide (10 μg/ml). The drug effects on the characteristics of action potential at the basic cycle lengths (BCLs) of 500 and 1,000 ms were similar to those reported previously. At control, the range of premature APDs was ∼40 ms at BCL of 1,000 ms and ∼30 ms at BCL of 500 ms. It was decreased 26-52% by lidocaine, mexiletine, and flecainide, not changed significantly by procainamide, and increased 17-53% by quinidine and disopyramide. The range of premature APDs at control and in the presence of drugs in ventricular muscle was smaller than in Purkinje fibers at the same or lower drug concentrations (Varro et al., J Pharmacol Exp Ther 1985; 233:304). The four factors influencing the premature APD range in the Purkinje fibers operated in the VM as follows: The difference between the duration of effective refractory period (ERP) and the APD at BCL (APDb) (i.e., the ERP-APDb interval) was increased by lidocaine, mexiletine, and flecainide; normalized restitution curve was shifted toward longer premature APD values only by flecainide; the kinetics of restitution were slowed only by procainamide; and APD at BCL of 1,000 ms was shortened by lidocaine and mexiletine, and prolonged at BCLs of 1,000 and 500 ms by the other four drugs. Unlike the Purkinje fibers, the range of premature APDs in VM was influenced chiefly by APD at BCL. The lengthening of the premature APD range by quinidine and disopyramide suggests that these drugs may be expected to increase dispersion of repolarization during the propagation of an early premature impulse, and that this increase may be greater at long than at short BCL.

KW - Dispersion of repolarization

KW - Effective refractory period

KW - Restitution of action potential duration

KW - Sodium channel blocking drugs

UR - http://www.scopus.com/inward/record.url?scp=0023627508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023627508&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 407

EP - 414

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 4

ER -